Human herpesvirus-6 (HHV-6) and HHV-7 infections in bone marrow transplant recipients

Critical Reviews in Oncology/Hematology

Volumn 32, Issue 3, 1999, Pages 187-196

  Peiris, Malik ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR;

BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; PNEUMONIA; POLYMERASE CHAIN REACTION; RASH; REVIEW; VIRUS CARCINOGENESIS; VIRUS CULTURE; VIRUS TRANSMISSION;

BONE MARROW TRANSPLANTATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MALE;

EID: 0032759108     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00046-3     Document Type: Review

References (104)

1. Salahuddin S.Z., Ablashi D.V., Markham P.D. et al. Isolation of a new virus, HBLV, in patients with lympho-proliferative disorders. Science. 234:1986;596-601.
2. Frenkel N., Schirmer E.C., Wyatt L.S. et al. Isolation of a new herpesvirus from human CD4+ T cells. Proc. Natl. Acad. Sci. USA. 87:1990;748-752.
3. Pellet PE, Black JB. Human herpesvirus 6. In: Fields BN, Knife DM, Howell PM, et al., editors. Fields Virology, vol. 2. 3rd ed. Philadelphia: Lippincott-Raven, 1996, pp. 2597-2608 [chapter 80].
4. Braun D.K., Dominguez G., Pellet P.E. Human herpesvirus 6. Clin. Microbiol. Rev. 10:1997;521-567.
5. Cone R.W., Huang M.-L.W., Hackman R.C. Human herpesvirus 6 and pneumonia. Leuk. Lymph. 15:1994;235-241.
6. Singh N., Carrigan D.R. Human herpesvirus 6 in transplantation: An emerging pathogen. Ann. Intern. Med. 124:1996;1065-1071.
7. Kimberlin D.W. Human herpesvirus 6 and 7: identification of newly recognised viral pathogens and their association with human disease. Pediatr. Infect. Dis. J. 17:1998;59-68.
8. Yoshikawa T., Suga S., Asano Y. et al. Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus 6) in healthy individuals. Pediatrics. 84:1989;675-677.
9. Hidaka Y., Kusuhara K., Takabayashi A. et al. Symptomatic primary infection with herpesvirus 6 variant A. Clin. Infect. Dis. 24:1997;1022-1023.
10. Cone R.W., Huang M.-L.W., Hackman R.C. et al. Co-infection with human herpesvirus 6 variants A and B in lung tissue. J. Clin. Microbiol. 34:1996;877-881.
11. DiLuca D., Mirandola P., Ravaioli T. et al. Distribution of HHV-6 variants in human tissues. Inf. Ag. Dis. 5:1996;203-214.
12. Hall C.B., Caserta M.T., Schnabel K.C. et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin. Infect. Dis. 26:1998;132-137.
13. Takahashi K., Sonoda S., Higashi K. et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol. 63:1989;3161-3163.
14. Downing R.G., Sewankambo N., Serwadda D. et al. Isolation of human lymphotropic herpesviruses from Uganda. Lancet. 2:1987;390.
15. Kondo K., Kondo T., Okuno T. et al. Latent human herpesvirus 6 infection in human monocytes/macrophages. J. Gen. Virol. 72:1991;1401-1408.
16. Fox J.D., Briggs M., Ward P.A. et al. Human herpesvirus 6 in salivary glands. Lancet. 336:1990;590-593.
17. Caserta M.T., Hall C.B., Schnabel K. et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J. Infect. Dis. 170:1994;1586-1589.
18. Rotola A., Ravaioli T., Gonelli A. et al. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. USA. 95:1998;13911-13916.
19. Katsafanas G.C., Schirmer E.C., Wyatt L.S. et al. In vitro activation of human herpesvirus 6 and 7 from latency. Proc. Natl. Acad. Sci. USA. 93:1996;9788-9792.
20. Inoue Y., Yasukawa M., Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J. Virol. 71:1997;3751-3759.
21. Horvat R.T., Parmely M.J., Chandran B. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J. Infect. Dis. 167:1993;1274-1280.
22. Burd E.M., Carrigan D.R. Human herpesvirus 6 (HHV-6) associated dysfunction of blood monocytes. Vir. Res. 29:1993;79-90.
23. Flammand L., Gosselin J., D'Addario M. et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis fator alpha, but not interleukin 6, in pheripheral blood mononuclear cells. J. Virol. 65:1991;5105-5110.
24. Diabata M., Taguchi T., Kamioka M. et al. Identification of integrated human herpesvirus 6 DNA in early pre-B cell acute lymphoblastic leukemia. Leukemia. 12:1998;1002-1004.
25. Sloots T.P., Kapeleris J.P., Mackay I.M. et al. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human serum. J. Clin. Microbiol. 34:1996;675-679.
26. Black J.B., Schwartz T.F., Patton J.L. et al. Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin. Diag. Lab. Immunol. 3:1996;79-83.
27. Chiu S.S., Cheung C.Y., Tse C.Y.C. et al. Early diagnosis of primary herpesvirus 6 infection in childhood: Serology, polymerase chain reaction, and virus load. J. Infect. Dis. 178:1998;1250-1256.
28. Ward K.N., Sheldon M.J., Gray J.J. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus 6 antibodies in immunosuppressed organ graft recipients: absence of virus cross reactivity and evidence for virus interaction. J. Med. Virol. 34:1991;258-267.
29. Linde A., Fridell E., Dahl H. et al. Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus and measles virus immunoglobulin titres. J. Clin. Microbiol. 28:1990;211-215.
30. Osman H.K., Peiris J.S.M., Taylor C.E. et al. Correlation between the detection of viral DNA by the polymerase chain reaction and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients. J. Med. Virol. 53:1997;288-294.
31. Ward K.N., Gray J.J., Joslin M.E. et al. Avidity of IgG antibodies to human herpesvirus 6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross reaction with other herpesviruses. J. Med. Virol. 39:1993;44-49.
32. Kadakia MP, Rubka WB, Stewart JA, et al. Human herpesvirus6: Infection and disease following autologous and allogeneic bone marrow transplantation, Blood 87:5341-5354.
33. Cone R.W., Huang M.L., Corey L. et al. Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virological manifestations. J. Infect. Dis. 179:1999;311-318.
34. Aberle S.W., Mandl C.W., Kunz C. et al. Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults. J. Clin. Microbiol. 34:1996;3223-3225.
35. Osman H.K.E., Peiris J.S.M., Taylor C.E. et al. Cytomegalovirus in renal allograft recipients: is human herpesvirus-7 a co-factor for disease progression? J. Med. Virol. 48:1996;295-301.
36. Chan P.K.S., Peiris J.S.M., Yuen K.Y. et al. Human herpesvirus 6 and human herpesvirus 7 infections in bone marrow transplant recipients. J. Med. Virol. 53:1997;295-305.
37. Wang F.-Z., Dahl H., Linde A. et al. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood. 88:1996;3615-3620.
38. Peiris J.S.M., Taylor C.E., Graham K. et al. Diagnosis of cytomegalovirus (CMV) disease in renal allograft recipients: The role of semi-quantitiative Polymerase Chain Reaction (PCR). Neph. Dial. Trans. 10:1995;1198-1205.
39. Yuen K.Y., Lo S.K.F., Chiu E.K.W. et al. Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR. J. Clin. Microbiol. 33:1996;2530-2535.
40. Drobyski W.R., Dunne W.M., Burd E.M. et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow suppressive role for HHV-6 in vivo. J. Infect. Dis. 167:1993;735-739.
41. Carrigan D.R., Drobyski W.R., Russler S.K. et al. Interstitial pneumonitis associated with human herpesvirus 6 infection after marrow transplantation. Lancet. 338:1991;147-149.
42. Knox K.K., Carrigan D.R. HHV-6 and CMV pneumonitis in immunocompromised patients. Lancet. 343:1994;1647.
43. Meyers J.D., Ljungman P., Fisher L.D. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: Importance of cytomegalovirus viremia. J. Infect. Dis. 162:1990;373-380.
44. Yamanishi K., Okuno T., Shiraki K. et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1:1988;1065-1067.
45. Hall C.B., Long C.E., Schnabel K.C. et al. Human herpesvirus 6 infection in children: a prospective study of complications and reactivation. N. Eng. J. Med. 331:1994;432-438.
46. Asano Y., Yoshikawa T., Suga S. et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics. 93:1994;104-108.
47. Yoshikawa T., Nakashima T., Suga S. Human herpesvirus 6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningo-encephalitis. Pediatrics. 89:1992;888-890.
48. Kondo K., Nagafuji H., Hata A. et al. Association of human herpesvirus 6 infection of the central nervous system with recurrences of febrile convulsions. J. Infect. Dis. 176:1993;1197-1200.
49. Huang L.M., Lee C.Y., Lin K.H. et al. Human herpesvirus 6 associated with fatal hemophagocytic syndrome. Lancet. 336:1990;60-61.
50. Asano Y., Yoshikawa T., Suga S. et al. Fatal fulminant hepatitis in an infant with human herpesvirus 6 infection. Lancet. 335:1990;862-863.
51. Sobue R., Miyazaki H., Okamoto M. et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N. Eng. J. Med. 324:1991;1290.
52. Yoshikawa T., Asano Y., Kobayashi I. et al. Exacerbation of idiopathic thrombocytopenic purpura by primary human herpesvirus 6 infection. Ped. Infect. Dis. J. 12:1993;409-410.
53. Akashi K., Eizuko Y., Sumiyoshi Y. et al. Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N. Eng. J. Med. 329:1993;168-171.
54. Levine P.H., Jahan N., Murari P. et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorman disease). J. Infect. Dis. 166:1992;291-295.
55. Sumiyoshi Y., Kikuchi M., Ohshima K. et al. Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi's disease) and other forms of lymphadenitis. Am. J. Clin. Pathol. 99:1993;609-614.
56. Carrigan D.R., Knox K.K. Human herpesvirus six and multiple sclerosis. Mult. Scler. 3:1997;390-394.
57. Lyall E.G.H., Cubie H.A. Human herpesvirus 6 DNA in the saliva of paediatric oncology patients and controls. J. Med. Virol. 47:1995;317-322.
58. Fairfax M.R., Schacker T., Cone R.W. et al. Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts. J. Infect. Dis. 169:1994;1342-1345.
59. Fujita H., Maruta A., Tomita N. et al. Human herpesvirus 6 associated exanthema in a patient with acute lymphocytic leukaemia. B. J. Haematol. 92:1996;947-949.
60. Diabata M., Ido E., Murakami K. et al. Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukaemia. Leukemia. 11:1997;882-895.
61. Yoshikawa T., Suga S., Asano Y. et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood. 78:1991;1381-1384.
62. Yoshikawa T., Suzuki K., Furukawa H. et al. Prediction of human herpesvirus 6 infection after allogeneic bone marrow transplantation. Blood. 92:1998;2597-2599.
63. Wilborn F., Brinkman V., Schmidt C.A. et al. Herpesvirus 6 in patients undergoing bone marrow transplantation; Serologic features and detection by polymerase chain reaction. Blood. 83:1994;3052-3058.
64. Frenkel N., Katsafanas G.C., Wyatt L.S. et al. Bone marrow transplant recipients harbour the B variant of human herpesvirus 6. Bone Marrow Trans. 14:1994;839-843.
65. Knox K.K., Carrigan D.R. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J. Infect. Dis. 165:1992;925-929.
66. Isamura H., Yamada M., Yoshida M. et al. Suppressive effects of human herpesvirus 6 on in-vitro colony formation of haemopoetic progenitor cells. J. Med. Virol. 52:1997;406-412.
67. Knox K.K., Carrigan D.R. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin. Infect. Dis. 22:1996;174-175.
68. Lau Y.L., Peiris M., Chan G.C.F. et al. Primary human herpesvirus 6 infection transmitted from donor to recipient through marrow infusion. Bone Marrow Trans. 21:1998;1063-1066.
69. Singh N., Carrigan D.R., Gayowski T. et al. Human herpesvirus 6 infection in liver transplant recipients. Transplantation. 64:1997;674-678.
70. Pitalia A.K., Liu-Yin J.A., Freemont A.J. et al. Immunohistochemical detection of human herpesvirus 6 in formalin fixed paraffin embedded lung tissue. J. Med. Virol. 41:1993;103-107.
71. Hammerling J.A., Lambrecht R.S., Kehl K.S. et al. Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis. J. Clin. Pathol. 49:1996;802-804.
72. Cone R.W., Hackman R.C., Huang M.W. et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N. Eng. J. Med. 329:1993;156-161.
73. McCullers J.A., Lakeman F.D., Whitley R.J. Human herpesvirus 6 is associated with focal encephalitis. Clin. Infect. Dis. 21:1995;571-576.
74. Drobyski W.R., Knox K.K., Majewski D. et al. Brief report: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone-marrow transplant recipient. N. Eng. J. Med. 330:1994;1356-1360.
75. Wang FZ, Linde A, Hagglund H et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogenic bone marrow transplant patients: does it have clinical significance. Clin Infect Dis. 28:1999;562-568.
76. . Michel D., Muller S., Worz S. et al. Human herpesvirus 6 DNA in exanthematous skin rash in BMT patient. Lancet. 344:1994;686.
77. Appleton A.L., Peiris J.S.M., Taylor C.E. et al. Human herpesvirus 6 DNA in skin biopsy tissue from marrow graft recipients with severe combined immunodeficiency. Lancet. 344:1994;1361-1362.
78. Appleton A.L., Sviland L., Peiris J.S.M. et al. Human herpesvirus 6 infection in marrow graft recipients: role in pathogenesis of frat-versus-host disease. Bone Marrow Trans. 16:1995;777-782.
79. Agut H., Aubin J.T., Huraux J.M. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. J. Infect. Dis. 163:1991;1382-1383.
80. Akesson-Johansson A., Harmenberg J., Wahren B. et al. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxy-methyl)butyl] guanine (2HM-HBG) and other antiviral compounds. Antimicrob. Agents Chemother. 34:1990;2417-2419.
81. Prentice H.G., Gluckman E., Powles R.L. et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet. 343:1994;749-753.
82. Yoshida M, Yamada M, Tsukazaki T et al. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res. 40:1998;73-84.
83. Razzaque A., Williams O., Wang J. et al. Neoplastic transformation of immortalised keratinocytes by two HHV-6 DNA clones. Virology. 195:1993;113-120.
84. Jarrett R.F., Gledhill S., Qureshi F. et al. Identification of human herpesvirus-6 specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia. 2:1988;496-502.
85. Torrelli G, Marasca R, Montorsi M et al. Human herpesvirus 6 in non-AIDS related Hodgkin's and non-Hodgkin's lymphomas, Leukemia 1992;6 (Suppl 3):46S-48S.
86. Schehofer B., Blettner M., Gelentnkey K. et al. Seroepidemiological analysis of the rash of virus infections in childhood leukaemia. Int. J. Cancer. 65:1996;584-590.
87. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol. 70:1996;5975-5989.
88. Nakagawa N., Mukai T., Sakamoto J. et al. Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies. J. Gen. Virol. 78:1997;1131-1137.
89. Lusso P, Secchiero P, Crowley RW et al. CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus, Proc Natl Acad Sci 91:3872-3876.
90. Wyatt L.S., Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J. Virol. 66:1992;3206-3209.
91. Takahashi Y., Yamada M., Nakamura J. et al. Transmission of human herpesvirus 7 through multigenerational families in the same household. Pediatr. Infect. Dis. 16:1997;975-978.
92. Asano Y., Suga S., Yoshikawa T. et al. Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics. 95:1995;187-190.
93. Tanaka K., Kondo T., Torigoe S. et al. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J. Pediatr. 125:1994;1-5.
94. Kawa-Ha K., Tanaka K., Inoue M. et al. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br. J. Haematol. 84:1993;545-548.
95. Torigoe S., Tabata N., Yamada M. et al. Prolonged viraemia and immune responses to human herpesvirus 7 in an infant with liver dysfunction. Pediatrics. 100:1997;398-400.
96. Torigoe S., Koide W., Yamada M. et al. Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediatr. 129:1996;301-305.
97. Black J.B., Burns D.A., Goldsmith C.S. et al. Biologic properties of human herpesvirus 7 strain SB. Vir. Res. 52:1997;25-41.
98. Dockrell D.H., Prada J., Jones M.F. et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J. Infect. Dis. 176:1997;1135-1140.
99. DesJardin J.A., Gibbons L., Cho E. et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis. 178:1998;1783-1786.
100. Tong CYW, Peiris M, Williams H, et al. Clinical interaction of human herpesvirus 6 and 7 with human cytomegalovirus after renal transplantation. In: The Third International Conference on Human herpesvirus 6,7 and 8. Tampa, Florida, March 1999. Abstract.
101. + T cells. J. Immunol. 152:1994;5768-5775.
102. Atedzoe B.N., Ahmad A., Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 IL-15 induction. J. Immunol. 159:1997;4966-4972.
103. Razzaque A, Jones C. Characterisation of a transactivator protein identified in the transactivating domain ZVH14 of human herpesvirus 6: Activation of heterologous promoters including the H-RAS. In: The Twentieth International Herpesvirus Workshop, Groningen. Abstract 182, 1995.
104. Flamand L., Stefanescu I., Ablashi D.V. et al. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J. Virol. 67:1993;6768-6777.